Leung, W.-H.; Shih, J.-W.; Chen, J.-S.; Mokgautsi, N.; Wei, P.-L.; Huang, Y.-J.
Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377. Biomedicines 2025, 13, 547.
https://doi.org/10.3390/biomedicines13030547
AMA Style
Leung W-H, Shih J-W, Chen J-S, Mokgautsi N, Wei P-L, Huang Y-J.
Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377. Biomedicines. 2025; 13(3):547.
https://doi.org/10.3390/biomedicines13030547
Chicago/Turabian Style
Leung, Wai-Hung, Jing-Wen Shih, Jian-Syun Chen, Ntlotlang Mokgautsi, Po-Li Wei, and Yan-Jiun Huang.
2025. "Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377" Biomedicines 13, no. 3: 547.
https://doi.org/10.3390/biomedicines13030547
APA Style
Leung, W.-H., Shih, J.-W., Chen, J.-S., Mokgautsi, N., Wei, P.-L., & Huang, Y.-J.
(2025). Correction: Leung et al. Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling. Biomedicines 2022, 10, 377. Biomedicines, 13(3), 547.
https://doi.org/10.3390/biomedicines13030547
